Implementation and Evaluation of the Electron Arc Plan on a Commercial Treatment Planning System with a Pencil Beam Algorithm.
- Author:
Sei Kwon KANG
1
;
Soah PARK
;
Taejin HWANG
;
Kwang Ho CHEONG
;
Me Yeon LEE
;
Kyoung Ju KIM
;
Do Hoon OH
;
Hoonsik BAE
Author Information
1. Department of Radiation Oncology, Hallym University College of Medicine, Seoul, Korea. thinkrun@hallym.or.kr
- Publication Type:Original Article
- Keywords:
Electron arc plan;
Pencil beam algorithm;
Plan system commissioning
- MeSH:
Electrons;
Film Dosimetry;
Particle Accelerators
- From:Korean Journal of Medical Physics
2010;21(3):304-310
- CountryRepublic of Korea
- Language:English
-
Abstract:
Less execution of the electron arc treatment could in large part be attributed to the lack of an adequate planning system. Unlike most linear accelerators providing the electron arc mode, no commercial planning systems for the electron arc plan are available at this time. In this work, with the expectation that an easily accessible planning system could promote electron arc therapy, a commercial planning system was commissioned and evaluated for the electron arc plan. For the electron arc plan with use of a Varian 21-EX, Pinnacle3 (ver. 7.4f), with an electron pencil beam algorithm, was commissioned in which the arc consisted of multiple static fields with a fixed beam opening. Film dosimetry and point measurements were executed for the evaluation of the computation. Beam modeling was not satisfactory with the calculation of lateral profiles. Contrary to good agreement within 1% of the calculated and measured depth profiles, the calculated lateral profiles showed underestimation compared with measurements, such that the distance-to-agreement (DTA) was 5.1 mm at a 50% dose level for 6 MeV and 6.7 mm for 12 MeV with similar results for the measured depths. Point and film measurements for the humanoid phantom revealed that the delivered dose was more than the calculation by approximately 10%. The electron arc plan, based on the pencil beam algorithm, provides qualitative information for the dose distribution. Dose verification before the treatment should be mandatory.
